MDCX Latest Press Releases

-- February 12, 2026 --

Medicus Pharma on Bloomberg World ACCESS Newswire 7:30 AM

-- February 10, 2026 --

Medicus Pharma Receives FDA "Study May Proceed" Clearance For Teverelix Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk Globe Newswire 7:30 AM

-- January 23, 2026 --

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony ACCESS Newswire 7:30 AM

-- January 22, 2026 --

Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix Long-Term Economic and Development Profile Globe Newswire 7:30 AM

-- January 20, 2026 --

Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026 Globe Newswire 7:30 AM

-- January 12, 2026 --

Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women Globe Newswire 7:30 AM

-- January 5, 2026 --

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates Globe Newswire 7:30 AM

-- December 22, 2025 --

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform ACCESS Newswire 7:30 AM

-- December 15, 2025 --

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin Globe Newswire 7:30 AM

-- December 5, 2025 --

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement ACCESS Newswire 3:21 PM

-- December 4, 2025 --

Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch AB Digital Inc 2:51 PM

-- December 1, 2025 --

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President ACCESS Newswire 8:00 AM

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President Globe Newswire 7:30 AM

-- November 24, 2025 --

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers Globe Newswire 8:00 AM

-- November 17, 2025 --

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire 7:30 AM

-- November 14, 2025 --

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights ACCESS Newswire 5:00 PM

-- November 13, 2025 --

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire 7:30 AM

-- November 5, 2025 --

Medicus Pharma Ltd. (NASDAQ: MDCX) and the Patch That Could End Repetitive Cancer Surgeries AB Digital Inc 3:05 PM

-- October 30, 2025 --

Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP) AB Digital Inc 2:49 PM

-- October 29, 2025 --

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome ACCESS Newswire 7:30 AM

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT in Patients with Gorlin Syndrome Globe Newswire 7:30 AM

-- October 23, 2025 --

4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA) AB Digital Inc 3:11 PM

-- October 22, 2025 --

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire 7:30 AM

-- October 16, 2025 --

4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH) AB Digital Inc 4:12 PM

-- October 14, 2025 --

The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets ACCESS Newswire 8:07 AM

-- October 13, 2025 --

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 ACCESS Newswire 7:30 AM

-- October 10, 2025 --

Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology AB Digital Inc 2:54 PM

-- October 7, 2025 --

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE ACCESS Newswire 7:30 AM

-- October 2, 2025 --

Medicus Pharma (Nasdaq: MDCX) Bringing Scar-Free, Outpatient Treatment to an $8 Billion Cancer Market AB Digital Inc 3:19 PM

-- September 29, 2025 --

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject ACCESS Newswire 7:30 AM

-- September 24, 2025 --

Medicus Pharma Ltd. To Present at Brookline Capital Markets ACCESS Newswire 7:30 AM